Spectrum Pharma (SPPI) Misses Q3 EPS by 3c, Offers FY Guidace
Tweet
Share
E-mailGet Alerts SPPI Hot Sheet
Price: $1.03 --0%
Financial Fact:
Income (loss) before provision for income taxes: -17.92M
Today's EPS Names:
VISL, GNLN, AFIB, More
Financial Fact:
Income (loss) before provision for income taxes: -17.92M
Today's EPS Names:
VISL, GNLN, AFIB, More
Join SI Premium – FREE
Spectrum Pharma (NASDAQ: SPPI) reported Q3 EPS of ($0.28), $0.03 worse than the analyst estimate of ($0.25).
2015 Financial Guidance
Spectrum raises guidance on year-end cash to over $125 million, up from the Company’s previous guidance of $110 million excluding any new business development transactions.
For earnings history and earnings-related data on Spectrum Pharma (SPPI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
- Vivos Therapeutics (VVOS) Tops Q2 EPS by 6c
- Greenlane Holdings Inc. (GNLN) reported Q2 result
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
